Literature DB >> 11262681

Gender and blindness: a meta-analysis of population-based prevalence surveys.

I Abou-Gareeb1, S Lewallen, K Bassett, P Courtright.   

Abstract

BACKGROUND: Many individual surveys of blindness have reported slightly higher rates of blindness for women. In order to gain a continent-by-continent and global sense of the burden of blindness by sex we conducted a meta-analysis of published, population-based surveys of blindness.
METHOD: Published reports were collected using a predetermined search protocol involving commercial electronic databases, hand-searching of references and direct contact with researchers. Studies were included that were population-based, included clinical examination and had a minimum sample size of 1000. The studies were critically appraised to determine methodological rigour. Data were analysed using the Cochrane Collaboration Review Manager.
RESULTS: The overall odds ratio (age-adjusted) of blind women to men is 1.43 (95% CI 1.33-1.53), ranging from 1.39 (95% CI 1.20-1.61) in Africa, 1.41 (95% CI 1.29-1.54) in Asia, and 1.63 (95% CI 1.30-2.05) in industrialised countries. There was good homogeneity of findings from Africa, Asia, and the industrialised countries. Globally, women bear excess blindness compared to men. In these surveys, overall, women account for 64.5% of all blind people. The excess of blindness in women was marked among the elderly and not due only to differential life expectancy.
CONCLUSION: The excess burden of blindness among women is likely due to a number of factors, which are different in industrialised countries compared to developing countries. Particular attention to gender differences in blindness is needed in the creation of targets for blindness reduction and in the development of interventions.

Entities:  

Mesh:

Year:  2001        PMID: 11262681     DOI: 10.1076/opep.8.1.39.1540

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  79 in total

Review 1.  Blindness in Africa: present situation and future needs.

Authors:  S Lewallen; P Courtright
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

Review 2.  Socioeconomic status and blindness.

Authors:  R Dandona; L Dandona
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

3.  Sociodemographic characteristics associated with blindness in a Nile Delta governorate of Egypt.

Authors:  D Fouad; A Mousa; P Courtright
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

4.  Cataract surgical coverage and outcome in the Tibet Autonomous Region of China.

Authors:  K L Bassett; K Noertjojo; L Liu; F S Wang; C Tenzing; A Wilkie; M Santangelo; P Courtright
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

5.  Prevalence and causes of blindness and visual impairment in Muyuka: a rural health district in South West Province, Cameroon.

Authors:  J E Oye; H Kuper; B Dineen; R Befidi-Mengue; A Foster
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

6.  Increasing uptake of eye services by women.

Authors:  Susan Lewallen; Paul Courtright
Journal:  Community Eye Health       Date:  2006-12

7.  Improving gender equity in eye care: advocating for the needs of women.

Authors:  Paul Courtright; Susan Lewallen
Journal:  Community Eye Health       Date:  2007-12

8.  The prevalence of visual impairment and blindness in underserved rural areas: a crucial issue for future.

Authors:  H Hashemi; A Yekta; E Jafarzadehpur; A Doostdar; H Ostadimoghaddam; M Khabazkhoob
Journal:  Eye (Lond)       Date:  2017-04-21       Impact factor: 3.775

9.  Visual Impairment and Blindness in Adults in the United States: Demographic and Geographic Variations From 2015 to 2050.

Authors:  Rohit Varma; Thasarat S Vajaranant; Bruce Burkemper; Shuang Wu; Mina Torres; Chunyi Hsu; Farzana Choudhury; Roberta McKean-Cowdin
Journal:  JAMA Ophthalmol       Date:  2016-07-01       Impact factor: 7.389

Review 10.  Gender and glaucoma: what we know and what we need to know.

Authors:  Thasarat S Vajaranant; Sushma Nayak; Jacob T Wilensky; Charlotte E Joslin
Journal:  Curr Opin Ophthalmol       Date:  2010-03       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.